Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

January 2013 - FRMC

Adjustments to Inhaled Corticosteroids in Asthma
01/22/2013

Kristina Woodworth

Kristina Woodworth
A study in adults with mild-to-moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy has demonstrated that adjustments in therapy based on biomarkers or symptoms were no better than standard physician...
A study in adults with mild-to-moderate persistent asthma controlled with low-dose inhaled corticosteroid therapy has demonstrated that adjustments in therapy based on biomarkers or symptoms were no better than standard physician...
A study in adults with...
01/22/2013
First Report Managed Care
Pomalidomide in Multiple Myeloma Patients
01/22/2013

Tim Casey

Tim Casey
Atlanta—Patients with multiple myeloma who had primary refractory or relapsed and refractory disease had a significant improvement in progression-free and overall survival if they took pomalidomide plus low-dose dexamethasone compared with a...
Atlanta—Patients with multiple myeloma who had primary refractory or relapsed and refractory disease had a significant improvement in progression-free and overall survival if they took pomalidomide plus low-dose dexamethasone compared with a...
Atlanta—Patients with multiple...
01/22/2013
First Report Managed Care
Bendamustine and Rituximab to Treat Mantle Cell Lymphoma
01/22/2013

Tim Casey

Tim Casey
Atlanta—A phase 2, single-arm, multicenter study found that patients with mantle cell lymphoma who had received up to 3 prior courses of chemotherapy had an overall response rate of 82% to the combination treatment of bendamustine plus...
Atlanta—A phase 2, single-arm, multicenter study found that patients with mantle cell lymphoma who had received up to 3 prior courses of chemotherapy had an overall response rate of 82% to the combination treatment of bendamustine plus...
Atlanta—A phase 2, single-arm,...
01/22/2013
First Report Managed Care
Lenalidomide for Mantle Cell Lymphoma
01/22/2013

Tim Casey

Tim Casey
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle...
01/22/2013
First Report Managed Care
Ruxolitinib and Erythropoiesis-Stimulating Agents for Myelofibrosis
01/22/2013

Tim Casey

Tim Casey
Atlanta—A posthoc analysis of a phase 3 study found that patients with myelofibrosis who were receiving erythropoiesis-stimulating agents (ESAs) tolerated the concomitant use of ruxolitinib, a potent janus kinase 1 and 2 inhibitor. The...
Atlanta—A posthoc analysis of a phase 3 study found that patients with myelofibrosis who were receiving erythropoiesis-stimulating agents (ESAs) tolerated the concomitant use of ruxolitinib, a potent janus kinase 1 and 2 inhibitor. The...
Atlanta—A posthoc analysis of a...
01/22/2013
First Report Managed Care
Dabigatran Etexilate and Knee or Hip Replacement Surgery
01/22/2013

Tim Casey

Tim Casey
A study found that dabigatran etexilate was effective and well tolerated in patients undergoing total knee or hip replacement surgery.
A study found that dabigatran etexilate was effective and well tolerated in patients undergoing total knee or hip replacement surgery.
A study found that dabigatran...
01/22/2013
First Report Managed Care
AMG 145 Lowers LDL-C in Statin-Intolerant Patients
01/22/2013

Tim Casey

Tim Casey
Los Angeles—Patients with high cholesterol who cannot tolerate statins achieved reductions in low-density lipoprotein cholesterol (LDL-C) after taking AMG 145, an investigational drug, according to a global, phase 2, randomized, double-blind,...
Los Angeles—Patients with high cholesterol who cannot tolerate statins achieved reductions in low-density lipoprotein cholesterol (LDL-C) after taking AMG 145, an investigational drug, according to a global, phase 2, randomized, double-blind,...
Los Angeles—Patients with high...
01/22/2013
First Report Managed Care
Daily Intake of Multivitamin Does Not Reduce Risk of Cardiovascular Disease
01/22/2013

Tim Casey

Tim Casey
Los Angeles—Male physicians who took a multivitamin every day for more than a decade had similar rates of major cardiovascular events, total myocardial infarction, and total stroke compared with a group that took a placebo, according to a...
Los Angeles—Male physicians who took a multivitamin every day for more than a decade had similar rates of major cardiovascular events, total myocardial infarction, and total stroke compared with a group that took a placebo, according to a...
Los Angeles—Male physicians who...
01/22/2013
First Report Managed Care

Department

News Connection
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
01/22/2013

Kevin L. Carter

Kevin L. Carter
Over the years, sources of grafts in allogeneic hematopoietic stem-cell transplantation have evolved from bone marrow to filgrastim-stimulated peripheral blood, which has a much higher content of blood progenitor cells. Several large,...
Over the years, sources of grafts in allogeneic hematopoietic stem-cell transplantation have evolved from bone marrow to filgrastim-stimulated peripheral blood, which has a much higher content of blood progenitor cells. Several large,...
Over the years, sources of...
01/22/2013
First Report Managed Care
Conference Insider
Costs Associated with Acute Coronary Syndrome
01/22/2013

Tim Casey

Tim Casey
Los Angeles—A retrospective database analysis of >37,000 claims from employees and their dependents found that patients with acute coronary syndrome (ACS) had high short-term and long-term disability and related costs that are higher or...
Los Angeles—A retrospective database analysis of >37,000 claims from employees and their dependents found that patients with acute coronary syndrome (ACS) had high short-term and long-term disability and related costs that are higher or...
Los Angeles—A retrospective...
01/22/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Payers Spend Less For Chemotherapy in Physician Offices VS Hospitals
02/28/2018
A recent study found that chemotherapy costs were lower when the treatments were administered at physician’s offices compared to hospital outpatient facilities.
A recent study found that chemotherapy costs were lower when the treatments were administered at physician’s offices compared to hospital outpatient facilities.
A recent study found that...
02/28/2018
First Report Managed Care
News
Medicare physician pay cut reversal in Senate`s hands
06/07/2010
06/07/2010
First Report Managed Care
Choosing Therapy for Type 2 Diabetes Based on Patient-Related Variables
06/10/2015

Mary Beth Nierengarten

Mary Beth Nierengarten
With the expanding availability of multiple drugs to treat patients with type 2 diabetes, treatment can now be better tailored to the needs of each patient.
With the expanding availability of multiple drugs to treat patients with type 2 diabetes, treatment can now be better tailored to the needs of each patient.
With the expanding availability...
06/10/2015
First Report Managed Care
News
Health Insurers Seek Delay Of New Consumer-Friendly Coverage Forms
08/23/2011
08/23/2011
First Report Managed Care
News
Adjuvant Therapy Tied to Better Survival in High-Risk Merkel Cell Carcinoma
12/11/2014
Adjuvant chemoradiotherapy is associated with improved survival in patients with high-risk Merkel cell carcinoma of the head and neck.
Adjuvant chemoradiotherapy is associated with improved survival in patients with high-risk Merkel cell carcinoma of the head and neck.
Adjuvant chemoradiotherapy is...
12/11/2014
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2013 Volume 10 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement